By Bill Current, president and founder of the Current Consulting Group and publisher of Current Compliance* Drug abuse is up. Positive drug test results are up. The number of companies testing for marijuana is down. We know this from three major...
How can we help?
In its role as the voice for the drug and alcohol testing industry, one of the National Drug and Alcohol Screening Association’s priorities is to provide input representing members’ interests concerning drug and alcohol testing regulations. On June 1, NDASA submitted...
“What counts in life is not the mere fact that we have lived. It is what difference we have made to the lives of others that will determine the significance of the life we lead.”- Nelson Mandela Our industry lost a great mentor, leader, friend, and colleague this past...
By Michael Watson, Chief Revenue Officer, EVP, SOBRsafe COVID caused the world to coin a relatively new phrase seldom used before – “new normal.” And it quickly became applicable to the drug and alcohol testing industry as countless numbers of employers scrambled to...
New York State’s Department of Labor this month released FAQ guidance pertaining to the state's legal use of cannabis by adults 21 or older. According to the guidance, employers are prohibited from discriminating against an employee for using "cannabis...
By Jan Kornmann, CEO/Owner of KorManagement Services Can you believe it? Drug testing is 30 years old! Well, it’s really older than that, but it was 30 years ago when the Omnibus Transportation Act of 1991, the U.S. federal regulation that requires drug and alcohol...
At the end of 2020, the National Drug & Alcohol Screening Association introduced the NDASA Accreditation program for Collection Sites, Consortiums and Third-Party Administrators, Designated Employer Representatives and (coming soon) Substance Abuse Professionals....
For years, employers have been struggling with changing local and state marijuana laws and the impact on workplace drug screening programs. At least 33 states now allow medical use of marijuana and 11, plus Washington, D.C., also permit recreational use. Recently, we...
Over the last months as most of us have been at home, the National Drug and Alcohol Screening Association (NDASA) has focused on what working in the ‘new normal’ will look like for our industry. We’ve written about it, spoken to the experts, hosted virtual...
As we get ready to go back to work, businesses are facing new challenges and realities that are complicated by uncertainties about the progression of COVID-19. We know that it’s not just a matter of returning to normal. Continued social distancing, stringent cleaning...
Search this site
Stay in touch
Give to NDASA
Latest News & Updates
- Jun 08, 2022Where Are We and Where Are We Going? The State of Drug Testing and the Future
- Jun 07, 2022NDASA Responds to SAMHSA Proposed Rules for Oral Fluid Testing in Federal Workplaces
- Jun 07, 2022The Great Retention: How to Hold onto Your Most Valuable Asset, Your Employees
- Jun 07, 2022First-Time Conference Attendee Vows to Return
- Jun 02, 2022Conference 2022: Three Days Packed With Teaching, Learning, Business Building and Progress
Topics We Track
- Advocacy (3)
- Business Development (1)
- Committee Reports (1)
- DOT (5)
- Drug & Alcohol Testing (19)
- Drug Legislation (8)
- Feature (50)
- FMCSA (3)
- For Drug Testing Industry Professionals (14)
- For Employers and Workplace Safety & Wellness Professionals (12)
- Industry News (10)
- Marijuana & CBD (13)
- Member Benefits (1)
- Membership (3)
- NDASA Conference (10)
- NDASA Guidance (4)
- Opioids (2)
- Resources (21)
- Substance Use (1)
- Substance Use/Addiction (3)
- Training (1)
- Uncategorized (7)
- Workplace Safety (4)